[ET Net News Agency, 14 September 2026] HANSOH PHARMA (03692) rose 5.1% to HK$34.4.
It hits an intra-day high of HK$34.4, breaking above the 100-D SMA of HK$33.088, and an intra-day low of HK$32.48. The total shares traded was 7.08 million, with a value of HK$238.4m. The active buy/sell ratio is 67:33, with net buying turnover of HK$79.92m. CITIGROUP GLOBAL accounts for greatest net responsive buying turnover of HK$7.17m, with volume weighted average price of HK$33.933. ABN AMRO CLEARING HK accounts for greatest net responsive selling turnover of HK$28.62m, with volume weighted average price of HK$33.556.
The Hang Seng Index now rose 85 points, or 0.3% to 24,891; the Hang Seng China Enterprises Index now rose 32 points, or 0.4% to 8,279.
Basic Information| Nominal | 34.400 | % Chg | +5.13% |
| High | 34.400 | Low | 32.480 |
| Shares Tr | 7.08m | Turnover | 238.4m |
| 10-D SMA | 34.930 | %H.V | 66.562 |
| 20-D SMA | 34.259 | VWAP | 33.660 |
| 50-D SMA | 33.273 | RSI14 | 51.448 |
Status: Breaking above the 100-D SMA, active buy/sell ratio is 67:33, with net buying turnover of HK$79.92m
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| HANSOH PHARMA (03692) | 34.400 | +5.13 |
| SIHUAN PHARM (00460) | 0.740 | +2.78 |
| GRAND PHARMA (00512) | 4.860 | +2.64 |
| SBP GROUP (01177) | 5.490 | +4.57 |
| HENGRUI PHARMA (01276) | 45.160 | +3.20 |
| LIVZON PHARMA (01513) | 21.000 | +1.06 |
| LUYE PHARMA (02186) | 1.800 | Unchanged |
| FOSUN PHARMA (02196) | 17.050 | +4.41 |
| SH PHARMA (02607) | 11.130 | +0.91 |
| CHINARES PHARMA (03320) | 4.325 | +1.76 |
(ed)
